New York-based biotech firm Bright Minds Biosciences Inc. (Nasdaq: DRUG) filed its fiscal third quarter earnings on Wednesday, reporting net income of C$413,843 for the period that ended June 30, a dramatic year-over-year turnaround from the C$1.4 loss for its third quarter in 2023. Losses for the fiscal year-to-date came …
Blüm Holdings Inc. (OTCQB: BLMH) posted a net income of $23.4 million for the second quarter ending June 30, showing progress in its turnaround efforts. The company’s improved performance was largely attributed to the sale of its controlling interest in People’s First Choice LLC, which operated the Blüm Santa Ana …
… Nevada Officials Take Next Step To Stop Penalizing Boxers And MMA Fighters Over Marijuana · GOP senator demands cannabis rescheduling explanation …